RGEN Financial Facts
Research and development: 1.89MProduct revenue: 24.68M
See Full Income Statement
Inventories: 24.46M
Cash and cash equivalents: 157.65M
See Full Balance Sheet
Repligen Corporation (RGEN) Earnings
|
Expand Research on RGEN
| Next EPS Date | 11/3/26 | EPS Growth Rate | 0.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +16.8% | Revenue Growth Rate | +9.4% |
| Average % Move 1-Wk after EPS | -4.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/3/26  |
Q326 | N/A | $0.46 | N/A | N/A | $206.71M | = | N/A | N/A | ||
| 7/28/26 |
Q226 | $0.54 | $0.45 | +$0.09 | $204M | $201.47M | = |  | | Details | |
| 5/5/26 | Q126 | $0.48 | $0.38 | +$0.10 | $194M | $192.05M | = | | | Details | |
| 2/24/26 | Q425 | $0.49 | $0.44 | +$0.05 | $197.91M | $192.89M | = | | | Details | |
| 10/28/25 | Q325 | $0.46 | $0.42 | +$0.04 | $189M | $181.78M | = | | | Details | |
| 7/29/25 | Q225 | $0.37 | $0.39 | -$0.02 | $182M | $175.35M | = | | | Details | |
| 4/29/25 | Q125 | $0.39 | $0.35 | +$0.04 | $169M | $163.4M | = | | | Details | |
| 2/20/25 | Q424 | $0.44 | $0.41 | +$0.03 | $168M | $167.67M | = | | | Details |
